Total Results: 15797
One part of the federal health law gave hospitals financial incentives to improve patient care. Some invested big to make those changes and are worried about what losing that support would mean.
A new study, though small, finds extensive damage to commonly used medical scopes that could trap dangerous bacteria. That raises concerns about the potential for more outbreaks.
A lawsuit was filed Monday alleging that the three makers of insulin — Sanofi, Novo Nordisk and Eli Lilly — conspired to increase the price of their product.
Opinion pages nationwide offer thoughts on the possible pitfalls as well as how some of the ideas taking shape offer promise.
Doctors, hospitals and the federal government are all asking patients about their care as the health system is being transformed. But many experts question the science and technical infrastructure for capturing good data. Also in the news, a report from Connecticut looks at efforts to curb the number of people who are readmitted to a hospital after a nursing home stay.
Outlets report on news from Georgia, California, New Jersey, Wisconsin, Delaware, Hawaii, Colorado, Ohio, Arizona, Oregon, Texas, Minnesota, Florida and Virginia.
U.S. District Judge Amos Mazzant in Sherman, Texas, is holding the rule up while he considers a case brought by dialysis providers and patients. In his order, he says the groups are likely to win the case because the rule, issued by the Obama administration last month, was “arbitrary and capricious.”
The coalition is seeking to continue a move away from Medicare’s traditional fee-for-service model. Also, several groups, including the American Medical Association and the American Hospital Association, announce plans to lobby insurers to streamline prior authorization procedures.
Read recent commentaries about drug-cost issues.
News outlets report on stories related to pharmaceutical drug pricing.
J&J was the first major health care company to report results since the president’s scathing remarks on high drug prices.
Outlets report on news from California, Virginia, Michigan, Arizona, Nebraska, New Jersey, Illinois, Texas and Florida.
Republican plans to transform Medicaid could help set debate on the role of government and entitlements. Here’s an explanation of how it could work.
The industry is going hard on offense in an attempt to combat its negative image over pricing. The ad campaign will focus on research and development, but lawmakers, policy officials and health leaders have already criticized it as avoiding the real issues.
The Consumer Financial Protection Bureau reports in a new study that 59 percent of people contacted by a debt collector had outstanding medical bills.
A flow of Medi-Cal expansion dollars — and patients — has fueled significant growth, making clinics in California one of the linchpins of primary care under Obamacare.
Newborn sleep is a valuable commodity.
Kaleo will make the product free for those without insurance or families with low-income, but it’s setting a high price for insurance companies. Meanwhile, Mylan has not reached a settlement with the Department of Justice over how it classified the EpiPen under Medicaid.
Mallinckrodt will have to pay a $100 million fine to settle antitrust allegations. Stat looks at Martin Shkreli’s role in the investigation.
A selection of opinions on health care from around the country.